Literature DB >> 30552825

Regression of human immunodeficiency virus-associated oral Kaposi sarcoma with combined antiretroviral therapy: A case report and literature review.

Juliana Bertoldi Franco1,2, Loreto José Maureira Pena3, Fabiana Martins E Martins3,4, Marcio Augusto de Oliveira3, Karem L Ortega1,3.   

Abstract

BACKGROUND: Kaposi's sarcoma (KS) is the most prevalent malignant neoplasia in human immunodeficiency virus positive (HIV+) patients for which the primary mode of management was chemotherapy.
METHODS: We have presented the case of a newly diagnosed HIV+ male patient who was diagnosed with a pedunculated nodule in the anterior region of the hard palate, measuring 3.5 cm in diameter and with 2 months of evolution.
RESULTS: Histopathological examination confirmed the clinical hypothesis of KS. Soon after the diagnosis, the patient started using combined antiretroviral therapy (Biovir and Kaletra), presenting a significant reduction of the lesion after 4 weeks. With 1.5 cm in diameter, the lesion was surgically removed. The patient was followed-up for 10 years without any recurrence.
CONCLUSION: In antiretroviral-naive patients with a well-preserved immune system, the use of cART may be efficient in reducing the progression of the KS lesions, thus avoiding the use of chemotherapeutic agents.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  HIV; Kaposi's sarcoma; acquired immunodeficiency syndrome; highly active antiretroviral therapy; human herpesvirus-8; oral manifestations

Year:  2018        PMID: 30552825     DOI: 10.1002/hed.25446

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  1 in total

1.  A case of Kaposi's sarcoma of tonsil with profuse bleeding in an HIV-positive patient.

Authors:  Dorji Penjor; Aun Wee Chong
Journal:  SAGE Open Med Case Rep       Date:  2021-12-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.